SANA
Sana Biotechnology, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -7.7% ·
aliran saham +8.8% ·
posisi baru bersih -8.3%
— formula
Akumulasi terkonsentrasi — peningkatan saham di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +4 | 119.01M | $415.23M | +9 | −5 |
| Q1 2026 | 84 | -3 | 118.01M | $339.95M | +3 | −6 |
| Q4 2025 | 87 | +2 | 116.35M | $473.54M | +2 | — |
| Q3 2025 | 15 | -2 | 97.26M | $345.27M | — | −2 |
| Q2 2025 | 14 | 0 | 77.71M | $212.16M | +2 | −2 |
| Q1 2025 | 11 | -1 | 31.65M | $53.17M | +1 | −2 |
| Q4 2024 | 12 | -1 | 32.20M | $52.48M | +1 | −2 |
| Q3 2024 | 12 | +2 | 22.88M | $95.19M | +2 | — |
| Q2 2024 | 10 | — | 23.15M | $126.39M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 10.23M | -0.4% | $16.68M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 10.23M | -0.4% | $16.68M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 10.23M | -0.4% | $16.68M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 10.23M | -0.4% | $16.68M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (pasif) | 6.71M | — | $10.94M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Capital World Investors ✦ | 5.45M | 0.0% | $8.88M | 0.0% | Held | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasif) | 3.19M | +0.8% | $5.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasif) | 3.19M | +0.8% | $5.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 3.11M | +7.6% | $5.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 3.11M | +7.6% | $5.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.21M | +572.4% | $1.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Millennium Management ✦ | 728.90K | +1264.5% | $1.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 480.30K | +228.4% | $782,886 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 382.66K | +435.9% | $623,740 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 382.66K | +435.9% | $623,740 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 382.66K | +435.9% | $623,740 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 363.62K | Baru | $592,697 | 0.0% | New | 1 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 319.82K | +1838.3% | $521,303 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Marshall Wace ✦ | 21.32K | -94.6% | $34,755 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 21.32K | -94.6% | $34,755 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $592,697 | 0.0% |
Telah keluar
| Norges Bank | $790,313 | adalah 0.0% |
| D. E. Shaw & Co. | $196,964 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 199 pemegang, 163.30M saham, $468.43M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.